Wealthfront Advisers’s Omnicell OMCL Stock Holding History

Wealthfront Advisers’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,109	Closed	-$200K	–	807
2021 Q4	$200K	Buy	+1,109	New	+$192K	﹤0.01%	757

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wealthfront Advisers's OMCL Position: Q1 2022 in Review

Wealthfront Advisers sold out of Omnicell (OMCL) in Q1 2022, closing a stake of 1,109 shares — an estimated $200K sold.

Wealthfront Advisers first reported a position in OMCL in Q4 2021 and held it in 1 quarter. The position peaked at $200K in Q4 2021. 397 funds tracked by Wall St. Rank hold OMCL as of Q1 2022.

Wealthfront Advisers reported no remaining Omnicell position as of Q1 2022 after selling out during the quarter.
Wealthfront Advisers sold 1,109 Omnicell shares in Q1 2022, an estimated $200K.
Wealthfront Advisers first reported a position in Omnicell in Q4 2021 and held it in 1 quarter.
Wealthfront Advisers's Omnicell position peaked at $200K in Q4 2021.
397 funds tracked by Wall St. Rank held Omnicell as of Q1 2022.

Based on Wealthfront Advisers's 13F filing for Q1 2022, filed 16 May 2022.